LolA and LolB are conserved in Bacteroidota and are crucial for gliding motility and Type IX secretion

Introduction

The cell envelope of Gram-negative bacteria is composed of two membranes: the inner membrane (IM) delimiting the cytoplasm, and the outer membrane (OM) delimiting the periplasm. Residing in between these two membranes is an additional thin layer made of peptidoglycan. Unlike the IM, composed exclusively of phospholipids, the OM is an asymmetric bilayer, with phospholipids on the inner and lipopolysaccharide (LPS) on the outer leaflet, forming a dense network impermeable to most compounds1. Import of nutrients through the OM thus relies on integral outer membrane proteins called porins, water-filled channels that allow substrates to cross the OM. In addition, lipoproteins, proteins with an acylated N-terminus allowing their anchorage in the membrane, are found in both membranes and participate in many functions, including nutrient acquisition, stress sensing, cell morphology, transport, etc.1. In E. coli, the most abundant lipoprotein is Lpp, inserted into the inner leaflet of the OM, which anchors the peptidoglycan to the OM thus playing a crucial role in the envelope architecture2. OM lipoproteins are also part of membrane protein complexes crucial for envelope maturation and cell viability such as the BAM complex, responsible for β-barrel protein insertion and folding into the OM3 and the Lpt complex involved in LPS transport across the OM4. While in most studied bacteria, OM lipoproteins are mainly anchored facing the periplasm, it has recently been shown that surface-exposed lipoproteins are more widespread than initially thought, especially in bacteria of the phylum Bacteroidota (formerly Bacteroidetes), where they are crucial for nutrient acquisition5,6,7. Furthermore, OM lipoproteins are key elements of the gliding and Type 9 secretion systems (T9SS), two intertwined types of machinery that are a hallmark for and unique to Bacteroidota8.

Despite different localizations, lipoproteins share a common maturation pathway. They are synthesized in the cytoplasm and after translocation to the periplasm, mainly through the Sec machinery, their N-terminal cysteine is acylated by the action of three IM enzymes. Once lipidated, lipoproteins remain either in the IM or are targeted to the OM9. The periplasm is a hydrophilic aqueous environment, yet, lipoproteins having a hydrophobic moiety, they require a specific transport system1,10.

In E. coli, lipoproteins are transported to the OM by the Lol system, composed of five proteins: the LolCDE ATP-binding cassette (ABC) transporter, responsible for lipoprotein extraction from the IM; the periplasmic chaperone LolA, which transports lipoproteins through the periplasm and delivers them to the OM lipoprotein LolB that inserts them in the OM11. Strikingly, while the components of the Lol machinery are essential for cell viability in E. coli, they are only partially conserved throughout Gram-negative bacteria. Indeed, LolB seems to be present only in β- and γ-Proteobacteria12, while a bifunctional LolA, capable of both chaperoning and inserting lipoproteins in the OM, has recently been identified in α-Proteobacteria and Spirochetes13,14. In addition, bacteria such as Spirochetes and Bacteroidota abundantly expose lipoproteins on their surface5,9,15.

In Bacteroidota, lipoproteins are targeted to the surface by an N-terminal lipoprotein export signal (LES), however, how they cross the OM is still unknown16,17. In Spirochetes, such an export signal could not be identified, but lipoprotein surface localization is dependent on an Lpt-like pathway where a homolog of the LPS transporter LptD is responsible for lipoprotein surface translocation15. It remains, therefore, unknown how Bacteroidota insert lipoproteins into their OM and how they flip some of them to the surface.

Here, by in silico distant homolog prediction, we identify LolB homologs in bacteria of the phylum Bacteroidota and demonstrate that multiple LolA and LolB proteins co-exist within the same Bacteroidota species.

We show that in the Bacteroidota Flavobacterium johnsoniae, which encodes three LolA and two LolB homologs, one LolA and one LolB are involved in lipoprotein trafficking. Deletion of either of these determines a lack of gliding and T9 protein secretion and severe membrane alterations. Strikingly, despite the presence of several LolA and LolB homologs, we provide evidence that surface lipoprotein transport can work independently of these proteins in F. johnsoniae. Finally, the finding that F. johnsoniae can survive in the absence of all LolA and LolB proteins strongly supports the hypothesis that another pathway can transport OM lipoproteins in the absence of LolA and LolB in Bacteroidota.

Results

Flavobacterium johnsoniae encodes several LolA and LolB proteins

While the presence of LolA homologs has been reported in Bacteroidota, no LolB homologs have been identified in bacteria of this phylum by sequence similarity searches. We started from the hypothesis that Bacteroidota might encode distantly related LolB homologs with low sequence identity, but that would share a similar structure. To identify such homologs, we performed an in silico prediction analysis searching for remote homologs of E. coli LolB in F. johnsoniae (see Methods for more details).

This analysis identified two LolB homologs in F. johnsoniae: Fjoh_1066 (LolB1) and Fjoh_1084 (LolB2). Both candidates are predicted to encode an SPII signal sequence, in accordance with LolB being a lipoprotein. We performed the same analysis to search for E. coli LolA homologs and three proteins were identified: the two LolA already found by sequence similarity and reported in the literature (Fjoh_2111, LolA1, and Fjoh_1085, LolA2)18,19 and a third one, Fjoh_0605, LolA3. LolA is a periplasmic carrier and thus harbors an SPI signal allowing it to cross the IM via the Sec pathway and reach the periplasm20. All three LolA homologs carry such a signal sequence and are thus likely localized in the periplasm.

While genes Fjoh_2111 (lolA1), Fjoh_0605 (lolA3), and Fjoh_1066 (lolB1) are encoded in different genomic loci, genes Fjoh_1084 (lolB2) and Fjoh_1085 (lolA2) are part of an operon responsible for flexirubin biosynthesis. Flexirubin is thought to be localized in the OM, and thus LolA2 and LolB2 might be involved in the synthesis and/or transport of this pigment19,21.

Next, we modeled the F. johnsoniae LolA and LolB protein structures and compared their overall secondary and tertiary structures with respect to the crystal structures of their E. coli homologs (Fig. 1). F. johnsoniae LolA and LolB variants retain the main features of the E. coli unclosed β-barrel presenting a convex and a concave side, composed of 11 antiparallel β-strands in which helices (α- and/or 310-helices) are embedded (Fig. 1), and enclosed by an N-terminal α-helix. Among the LolA proteins, E. coli LolA (LolAEc) and LolA1 have the same mainly disordered C-terminal region with one short 310-helix as well as one extra parallel β-strand, while LolA2 and LolA3 have a shorter and longer C-terminal end, respectively. In addition, the E. coli LolB (LolBEc) specific feature, consisting of a protruding loop comprising an exposed hydrophobic amino acid, is conserved in LolB1 and LolB2 (Fig. 1). In LolBEc and LolB1 this is a leucine, while in LolB2 a phenylalanine. LolB2 is structurally closer to LolBEc than LolB1 which has a long N- and C-terminal disordered tail, as well as a very long loop extension compacted beneath the barrel.

Fig. 1: Structural comparison between E. coli and F. johnsoniae LolA and LolB homologs.
figure 1

Comparison of crystallized E. coli LolA (PDB entry: 1UA8) and LolB (PDB entry: 1IWM) structures with models of LolA1, LolA2, LolA3, LolB1, and LolB2 homologs from F. johnsoniae. Each protein is shown as a cartoon representation and secondary structure elements are colored as follows: α-helix (purple), 310-helix (blue), β-sheet (yellow), and coil (gray). On each structure, the N- and C-terminal positions are indicated. In LolA1, the loop extension between α-helix 3 and β-strand 7 is highlighted with a dashed green ellipse. In LolB, LolB1, and LolB2, the upward conserved loop is highlighted with a dashed red circle. In LolB1, the compacted loop extension between α-helix 3 and β-strand 7 is highlighted with a dashed blue ellipse.

Full size image

The mechanism of transfer of lipoproteins from LolAEc to LolBEc occurs via a complex formation through electrostatic potential complementarity, forming a contiguous hydrophobic surface, i.e., a tunnel-like structure, composed of both LolA and LolB concave sides. The lipoprotein is transferred due to a higher affinity of its lipid moiety for LolB than LolA due to a hydrophobic gradient between the cavities of the two partners22. LolAEc concave side, especially along the edge of the β-barrel opening, is enriched in negatively charged amino acids, interacting with the LolBEc convex side, which is mainly positively charged22. With this mechanism in mind, we compared the hydrophobicity (Supplementary Fig 1) and charge state (Supplementary Fig 2) of F. johnsoniae LolA and LolB homologs to highlight differences and, potentially predict LolA–LolB interactions.

An interesting tendency is a distinct enrichment in highly hydrophobic (leucine and isoleucine) amino acids highlighted for all the F. johnsoniae LolA and LolB homologs (Supplementary Table 1). Consequently, these are overall more hydrophobic than LolAEc and LolBEc, and LolA2 stands out as the most hydrophobic one. Furthermore, LolB1 contains a higher proportion of hydrophobic residues than LolA1, suggesting a favorable hydrophobic gradient for the lipoprotein transfer between LolA1 and LolB1. Although LolB2 has fewer hydrophobic residues than LolA2, its higher content in leucine and their local concentration within the concave side of the β-barrel could nonetheless allow the lipoprotein transfer toward LolB2 (Supplementary Fig 1). The same rationale can be applied to the putative LolA1-LolB1 couple. In the case of LolA3, the side chains pointing toward the inside of the concavity are substituted in tyrosine and isoleucine, increasing the overall polarity of the binding site. Regarding the electrostatic-driven LolAB paired complexes formation, a slight decrease in arginine compensated by a large increase in the lysine content is observed for all the F. johnsoniae proteins (Supplementary Table 1), especially for LolA1 and LolA2, changing the concave side charge from negative to mostly positive (Supplementary Fig 2). LolA3 seems closer to LolAEc, with a predominance of aspartate and glutamate residues on the concave side, giving it a global negative charge. Most remarkably, its unique long and disordered C-terminal region bears a high positive charge, due to a dense population of lysine. Furthermore, while the positive character of the LolB convex side is mainly conserved in its F. johnsoniae homologs, a more evocative negative charge is exhibited by the concave side, particularly at the level of the loop extension of LolB1, absent in LolBEc and LolB2 (Supplementary Fig 2). Therefore, the mechanism and preferential orientation by which LolA-LolB complexes are formed in F. johnsoniae most likely differ from that of E. coli, and pair selectivity will also arise from subtle modifications in hydrophobicity and charge distribution.

Deletion of lolA1 and lolB1 affects gliding motility and Type IX secretion

Transposon mutagenesis screens to identify gliding motility genes of F. johnsoniae and of another member of the Bacteroidota resulted in non-gliding mutants that had transposon insertions in lolA homologs18,23. The F. johnsoniae gene identified was Fjoh_2111, which we refer to as lolA1. Since LolA allows lipoproteins to cross the periplasm and localize to the OM, the lack of gliding of the Tn mutants could be due to mislocalization and consequent depletion of lipoproteins in the OM. To confirm the absence of motility reported for a lolA1 mutant and to determine whether deletion of any of the other F. johnsoniae LolA and LolB proteins could have a similar effect, we assessed the gliding motility of the lolA1, lolA2, lolA3, lolB1, and lolB2 mutants on plates. As expected, lolA1 deletion resulted in non-spreading colonies, and, a lack of motility comparable to that of a gldJ non-gliding mutant was also observed when lolB1 was deleted24 (Fig. 2a and Supplementary Movie 1). GldJ is an OM lipoprotein required for both gliding and T9 secretion24,25. Deletion of lolA2, lolA3, and lolB2 did not affect gliding. Co-deletion of both lolA1 and lolB1 resulted in the same phenotype as the single lolA1 mutant. Plasmid-borne complementation of lolA1 and lolB1 deletion with lolA1 and lolB1 fully restored gliding motility (Fig. 2a).

Fig. 2: Deletion of lolA1 and lolB1 affects gliding motility and Type IX secretion.
figure 2

Gliding motility on MM agar plates after 48 h (a). Starch degradation by T9-secreted amylases on LB starch plates after 24 h (b) and amylase activity of cell culture supernatants (c). Data in (c) is represented as means of n = 3 independent biological replicates ± standard deviation, and statistical analysis was a one-way ANOVA followed by Dunnett’s multiple comparison test (F (22, 46) = 47.47). Asterisks indicate the following: (****): p < 0.0001.

Full size image

Since gliding motility and T9 secretion are highly interlinked and both require several OM lipoproteins for their activity8,26, we next determined the impact of lolA and lolB homologs deletion on T9SS activity. This secretion system is unique to Bacteroidota and is involved in the secretion of various proteins mainly involved in adhesion and nutrient acquisition, such as α-amylases that allow F. johnsoniae to hydrolyze and feed on starch25. To monitor Type 9 secretion, we measured the starch degradation activity of secreted amylases on starch-containing plates and on cell culture supernatants. Starch degradation was significantly reduced in the lolA1, lolB1, and lolA1lolB1 mutant strains compared to the WT and like that of the gldJ mutant (Fig. 2b, c). Deletion of lolA2, lolA3, and lolB2 did not affect amylase secretion (Fig. 2b, c). Plasmid-borne complementation of lolA1 and lolB1 strains fully restored amylase secretion (Fig. 2b, c). The reduced amylase activity observed for the lolA1 and lolB1 mutants could not be ascribed to the lack of motility of these strains as a gldJ-548 mutant, which is non-motile but has an active T9SS8, degraded starch to the same extent as the WT strain (Fig. 2b, c).

Overall, these data indicate that LolA1 and LolB1 are crucial for both gliding motility and T9 secretion and reinforce our initial hypothesis that these two proteins might belong to the same pathway, namely the transport of a subset of lipoproteins to the OM. Given their pivotal role in F. johnsoniae, we focused on further characterizing the function of these two proteins.

Deletion of lolA1 and lolB1 affects outer membrane proteome composition

The absence of gliding and T9 secretion could be due to mislocalization of OM lipoproteins crucial for these pathways in the absence of LolA1 and LolB1. To test this hypothesis, we determined the impact of lolA1 and lolB1 deletion on the OM protein composition of bacteria grown in CYE-rich medium. We purified the OM of WT, lolA1, and lolB1 strains and identified proteins by mass spectrometry. Overall, the absence of lolA1 or lolB1 respectively affected 609 and 171 proteins in a significant manner (fold change ≥ 1.5; significance ≥ 20) (Fig. 3a, Supplementary Data 1 and 2). We sorted the proteins according to their localization: cytoplasmic (no SP), integral OM and soluble periplasmic proteins (SPI), periplasmic-facing lipoproteins (SPII), and surface-exposed lipoproteins (SPII-LES). The OM proteome of the WT and lolB1 mutant was enriched in membrane proteins and lipoproteins while, that of the lolA1 mutant contained many cytoplasmic proteins, accounting for 66% of significant entries (402 out of 609) hinting at possible intracellular protein leakage as also suggested by the extracellular debris and cell material observed by electron microscopy for this mutant (Fig. 3a, Supplementary Data 2 and Supplementary Fig. 3). We clustered proteins harboring an SP by predicted function and mapped those involved in polysaccharide utilization to their respective(s) polysaccharide utilization loci (PULs)27.

Fig. 3: The OM protein composition of lolA1 and lolB1 mutants is altered compared to the WT.
figure 3

Proteins identified by mass spectrometry whose abundance significantly differs (FC ≥ 1.5, significance ≥ 20) in the OM fraction of the lolA1 and lolB1 deleted strains compared to the WT clustered by predicted localization (SignalP server). SPI signal peptide I (OMP or periplasmic), SPII periplasmic-facing lipoproteins, SPII-LES surface-exposed lipoproteins (a). Proteins with an SP whose abundance is affected in the OM fraction of the lolA1 and lolB1 mutants compared to the WT clustered by functional class (EggNOG) (b). Gliding and T9SS-specific proteins whose abundance is altered in lolA1 and/or lolB1 OM compared to the WT (c).

Full size image

In both mutants, the most affected known cellular functions were polysaccharide utilization (2 proteins increased (+) and 45 decreased (−) in lolA1, +6/−14 in lolB1) and cell wall/membrane/envelope biogenesis (+5/−21 in lolA1, +5/−12 in lolB1). In addition, several gliding/T9 secretion-specific proteins were affected (+3/−9 in lolA1, +3/−6 in lolB1). Overall, 207 SPI/SPII proteins were impacted by the deletion of lolA1 and 106 by the deletion of lolB1 (Fig. 3b). Among these, the abundance of 59 proteins was decreased in both mutants and among them several gliding/T9 secretion-related proteins (Fig. 3c). GldK and GldJ, two lipoproteins essential for gliding motility and T9 secretion28 were much less abundant in the OM of the lolA1 and lolB1 mutants than in the WT strain (GldK FC in lolA1 = 0.48 and 0.08 in lolB1; GldJ FC in lolA1 = 0.05 and 0.22 in lolB1). GldN, another critical component of the gliding and T9 types of machinery and the physical partner of GldK29,30 was also less abundant (FC = 0.53 in lolA1 and 0.33 in lolB1). One SprF-like protein (Fjoh_3951), implicated in T9 secretion28, was also less abundant in the OM of both mutants (FC = 0.16 in lolA1 and lolB1). We also noticed a few proteins potentially involved in envelope biogenesis whose amount in the OM was altered in the two mutants, namely a peptidoglycan-binding LysM protein (FC = 3.12 in lolA1 and 1.86 in lolB1), a BamB-like protein (FC = 0.44 in lolA1 and 0.57 in lolB1), a polysaccharide export protein Wza (FC = 0.27 in lolA1 and 0.23 in lolB1), and a peptidoglycan hydrolase (FC = 0.18 in lolA1 and 0.28 in lolB1).

Among the 148 proteins specifically affected by the deletion of lolA1, we found other components of the gliding/T9 secretion types of machinery (Fig. 3c). Among them, SprT (FC = 0.41), SprF (FC = 0.37), and SprD (FC = 0.05) are all required for gliding motility31,32. The absence of lolA1 resulted in the decrease of numerous OM proteins dedicated to polysaccharide utilization and inorganic ion transport (Fig. 3b) of which most were SusC-like proteins or TonB-dependent receptors, i.e., proteins with a β-barrel domain.

Within the 47 proteins specifically affected by the deletion of lolB1, we also found gliding/T9 secretion-related proteins (Fig. 3c). LolA1 amount was also increased in the lolB1 mutant (FC = 2.04). In contrast with the data specific to lolA1, we did not observe an obvious pattern in the data specific to lolB1. The loss of lolB1, as for lolA1, decreased the number of PUL-encoded proteins in the OM but to a much lower extent (Fig. 3b).

We did not observe a general mislocalization of OM lipoproteins upon deletion of lolA1 or lolB1, as one could have expected. Nevertheless, the proteomics data confirm and provide an explanation for the loss of gliding motility and T9 secretion that we observed for both mutants. Although the deletion of lolA1 or lolB1 alters the OM protein composition in different ways, bacteria lacking either of these two proteins fail to properly localize a subset of proteins and lipoproteins, including core components of gliding motility/T9 secretion such as GldN, GldK, and GldJ. While the deletion of lolA1 was more consequential for the OM of F. johnsoniae than the deletion of lolB1, the most impacted cellular functions (polysaccharide utilization and cell wall/membrane/envelope biogenesis) were in common. Considering that the abundance of several OM lipoproteins was altered in both mutants, our data suggest that lolA1 and lolB1 participate in the same pathway, i.e., the transport of lipoproteins to the OM and, in particular, lipoproteins involved in gliding motility and T9 secretion. Yet, lolA1 deletion clearly determined a bigger perturbation of the OM proteome. Among the IM and cytoplasmic proteins identified in the proteomic analysis, the majority were more abundant in the lolA1 (323 out of 402) and lolB1 (38 out of 66) mutants OM compared to the WT, thus pointing to some envelope defects of these mutants, probably more pronounced in the absence of LolA1 (Supplementary Data 2).

Deletion of lolA1 and lolB1 affects growth and cell morphology

The OM proteome composition alterations observed prompted us to test whether the lack of LolA1 and LolB1 would affect bacterial fitness. To this aim we monitored the growth of these mutants in two media, casitone yeast extract (CYE), the rich medium normally used to grow F. johnsoniae and motility medium (MM) a poor medium that stimulates gliding motility33.

As shown in Fig. 4a, all mutants grew like the WT in CYE. In contrast, in MM, the deletion of lolA1 severely impacted growth while the deletion of lolB1 did not (Fig. 4a). In the absence of both LolA1 and LolB1 growth was comparable to that of the single lolA1 mutant. Plasmid-borne complementation of lolA1 and lolA1lolB1 mutants with lolA1 and lolA1 and lolB1 fully restored growth to the WT levels (Fig. 4a). Deletion of any of the other LolA and LolB proteins did not affect growth in any condition tested (Fig. 4a).

Fig. 4: Deletion of lolA1 and lolB1 affects growth and cell morphology.
figure 4

Growth curves of WT and mutant strains in CYE and MM liquid media. Data are represented as means of n = 3 independent biological replicates ± standard deviation (a). Phase-contrast microscopy images of bacteria grown for 16 h in CYE and MM media (bar = 5 µm) (b).

Full size image

Next, we assessed whether the mutations had any morphological effect on bacteria. We observed by optic and transmission electron microscopy cells grown for 16 h in CYE medium and found that lolA1 bacteria presented some aberrant shapes, some resembling the shape of a lollipop, while others being completely round (Fig. 4b and Supplementary Fig. 3). The same abnormal morphologies, along with more cell aggregation, were also observed in the lolA1lolB1 double mutant, while lolB1 mutants resembled the WT strain. Both lolA1 and lolA1lolB1 mutants displayed detached OM and release of intracellular material as a result of severe envelope defects (Supplementary Fig. 3). The aberrant cell morphology phenotype of the lolA1 and lolA1lolB1 strains was enhanced when bacteria were grown in MM and the formation of abnormal cells was also observed for the lolB1 mutant in this medium (Fig. 4b). Lack of any of the other LolA and LolB proteins did not affect cell morphology in either CYE or MM (Supplementary Fig. 4). Complementation of lolA1, lolB1, and lolA1lolB1 with plasmid-borne lolA1, lolB1, and lolA1 and lolB1 fully restored the cell morphology to WT levels (Fig. 4b).

Overall, while growth in the MM medium was affected only by the deletion of lolA1, the deletion of lolA1 and lolB1 affected cell morphology, in particular in MM for this latter mutant. Co-deletion of lolA1 and lolB1 determined an enhancement in abnormal cell morphology in both CYE and MM (Fig. 4b and Supplementary Fig. 3).

Deletion of lolA1 and to a minor extent of lolB1 affects envelope integrity

The observed growth and morphological phenotypes of the lolA1 mutant when grown in MM hinted to a possible membrane instability. A main difference in composition between these two media is the absence of magnesium in the form of MgSO4 in MM. Divalent cations and, in particular, magnesium, are known to stabilize LPS–LPS interactions34. In bacteria with OM alterations due to protein and/or lipid shifts, magnesium has been shown to compensate for these phenotypes. We thus tested whether the growth defect and morphology changes observed for the lolA1 and lolB1 mutants could be rescued by magnesium supplementation in MM. As shown in Fig. 5, the addition of 8 mM MgSO4 (as in CYE) to MM restored growth (Fig. 5a) of the lolA1 and lolA1lolB1 mutants, thus suggesting an alteration of the OM of these mutants. Concerning cell morphology, the addition of magnesium alleviated abnormal cell morphologies of the mutants but did not totally restore them to WT levels (Fig. 5b).

Fig. 5: Impact of deletion of lolA1 and of lolB1 on OM integrity and stress sensitivity.
figure 5

Growth curves of WT and mutant strains in MM liquid medium without and with 8 mM MgSO4. Data are represented as means of n = 3 independent biological replicates ± standard deviation (a). Phase-contrast microscopy images of bacteria grown in liquid MM medium without and with 8 mM MgSO4 (bar = 5 µm) (b). Growth after 24 h in CYE liquid medium in the presence of different OM perturbing agents (SDS, Polymyxin B, and EDTA) (c). Data in c are represented as means of n = 3 biological independent replicates ± standard deviation, and statistical analysis was a one-way ANOVA followed by Tukey’s multiple comparison test (SDS 0.001% F (3, 8) = 6.602; SDS 0.005% F (3, 8) = 440.9; Polymyxin B 2 µg/ml F (3, 8) = 43.21; Polymyxin B 20 µg/ml F (3, 8) = 540.5; Polymyxin B 40 µg/ml F (3, 8) = 669.9; EDTA 0.2 mM F (3. 8) = 4.37; EDTA 1 mM F (3, 8) = 99.03). Asterisks indicate the following: (*): p < 0.0332, (**): p < 0.0021, (***): p < 0.0002, (****): p < 0.0001, (ns): p > 0.05).

Full size image

We also tested whether lolA1 and/or lolB1 deletion might affect the sensitivity of the mutants to several OM perturbing agents, namely SDS, Polymyxin B, and EDTA. We observed that while deletion of lolA1 and/or lolB1 did not affect growth at low SDS concentrations, the lolA1 mutant showed significant growth impairment at a higher concentration (Fig. 5c). The lolB1 strain also showed reduced growth although to a lesser extent than the lolA1 mutant (Fig. 5c). The lolA1lolB1 double mutant showed a phenotype like the lolA1 mutant. Polymyxin B affected the growth of the three mutants in a similar concentration-dependent fashion (Fig. 5c). In contrast, EDTA affected the growth of the lolA1 and lolA1lolB1 mutants, but not of the lolB1 mutant at the tested concentrations (Fig. 5c).

At an EDTA concentration of 1 mM, the lolA1lolB1 double mutant showed an increased sensitivity compared to that of the lolA1 mutant, meaning that the deletion of lolB1 in a lolA1 mutant background increases the sensitivity of bacteria to this compound.

Taken together, these results suggest that the deletion of lolA1 affects OM stability, as the lolA1 and lolA1lolB1 mutants showed acute sensitivity to all tested stresses. On the other hand, lolB1 single deletion seems to have a lower impact on OM stability, as this mutant was less sensitive than the lolA1 mutant to SDS and Polymyxin B and was resistant to EDTA. The increased sensitivity of the lolA1lolB1 double mutant to EDTA compared to the lolA1 single mutant supports our observations of cell morphology (Fig. 4b) as well as the idea that the deletion of both lolA1 and lolB1 is more detrimental to F. johnsoniae than their single deletion.

The protruding loop and the C-terminal region of LolB1 are crucial for its function

In E. coli LolB, the hydrophobic protruding loop between β-strands 3 and 4 is critical for lipoprotein insertion35. A highly conserved residue, Leu68, found at the tip of the loop has been shown to be crucial for LolB activity. When this leucine is replaced with a polar residue or deleted, LolB can no longer efficiently insert lipoproteins into the OM13,35. A loop is also present in LolB1 with a leucine (L74) at its tip (Fig. 6a). To see whether the loop and this residue are crucial for F. johnsoniae LoLB1 function, we tested whether the expression of LolB1 where Leu74 is replaced by the polar glutamate (L74E) or where the loop is deleted (residues 73–76) could complement the gliding and T9SS phenotypes of the lolB1 mutant. As shown in Fig. 6b, c, the LolB1L74E variant only partially restored gliding motility whereas amylase secretion was restored to WT levels. In contrast, deletion of the loop completely abolished gliding and secretion.

Fig. 6: The protruding loop and the C-terminal domain of LolB1 are crucial for its function.
figure 6

I-TASSER model of LolB1 with the protruding loop (in red) with the conserved L74 (in cyan) and the C-terminal domain (in blue) (a). Gliding on MM agar plates after 48 h and starch degradation on LB starch plates after 24 h of lolB1 mutants expressing: WT LolB1, LolB1L74E, LolB1∆73-76, LolB1∆223-243 and LolB1C17G (b). Amylase activity of the supernatant of WT and lolB1 mutants expressing: WT LolB1, LolB1L74E, LolB1∆73-76, LolB1∆223-243 and LolB1C17G (c). Data in c are represented as means of n = 3 independent biological replicates ± standard deviation, and statistical analysis was a one-way ANOVA followed by Dunnett’s multiple comparison test (F (22, 46) = 47.47). Asterisks indicate the following: (****): p < 0.0001. Detection by Western blot of C-terminally His-tagged: WT LolB1, LolB1L74E, LolB1∆73-76 and LolB1∆223-243. GroEL protein levels are shown and serve as a loading control (d).

Full size image

These data suggest that the loop and the conserved Leu are important for LolB1 function, as in E. coli LolB. Partial complementation of the LolB1L74E protein could not be ascribed to a different protein expression level of this mutation since the protein amount of WT LolB1 and LolB1L74E variants was comparable (Fig. 6d). In contrast, deletion of residues 73–76 of LolB1 (LolB1∆73-76) resulted in a significant reduction of protein amount, as shown by the weak signal in the western-blot and by MS detection (Fig. 6d and Supplementary Table 2), thus suggesting that this mutation affects protein stability or induces degradation of this non-functional LolB variant.

A main difference between E. coli LolB and LolB1 is the presence of a C-terminal domain that could not be folded by modeling software (Fig. 6a). We wondered whether this domain could be important for LolB1 function and thus deleted it (lolB1Δ223–243). This mutant LolB1 could only partially complement gliding while amylase secretion was like WT levels (Fig. 6b, c). As for LolB1∆73-76, deletion of the C-terminal domain determined a significant reduction in the protein levels, as shown by the weak signal in the western blot and low spectral count detected by MS (Fig. 6d and Supplementary Table 2). However, the evidence that deletion of the C-terminal tail of LolB1 still allows protein secretion despite determining the strongest reduction in protein levels (Supplementary Table 2), suggests that this deletion affects protein stability but not completely protein function as observed for the LolB1 73–76 residues deletion which abolished both gliding and secretion.

In E. coli, LolB does not require its lipid anchor to correctly insert lipoproteins in the OM36. To see if this was also the case for LolB1, we generated a periplasmic soluble form of LolB1, by introducing a C17G mutation in the signal peptide of LolB1 (LolB1C17G), thus replacing the lipidated cysteine and generating an SPI. In trans expression of LolB1C17G fully complemented lolB1 deletion in F. johnsoniae as shown by the recovered gliding motility and amylase secretion (Fig. 6b, c). As for E. coli LolB, lipidation does not seem to be crucial for F. johnsoniae LolB1 function.

Overall, these data support the evidence that LolB1 shares common features with E. coli LolB, as the loop, while having some compositional differences, and the C-terminal domain, both crucial for its function.

E. coli and F. johnsoniae LolA and LolB are not interchangeable

In silico structure comparison and protein characterization show high structural similarity between F. johnsoniae LolA1 and LolB1 and E. coli LolA and LolB respectively (Fig. 1) while highlighting some differences regarding hydrophobicity and charge distribution (Supplementary Figs. 1 and 2 and Supplementary Table 1). We thus wondered whether LolA and LolB from E. coli might complement the deletion of lolA1 and lolB1 in F. johnsoniae. In trans expression of LolAEc and LolBEc did not restore gliding nor T9 secretion of the lolA1 and lolB1 mutants (Fig. 7a–c). Similarly, co-expression of LolAEc and LolBEc did not restore gliding nor secretion of the lolA1lolB1 double mutant (Fig. 7a–c).

Fig. 7: E. coli LolA and LolB do not complement lolA1 and lolB1 deletion in F. johnsoniae.
figure 7

Gliding motility on MM agar plates after 48 h (a) and starch degradation on LB starch plates after 24 h (b). Amylase activity of cell culture supernatants (c). Data in c are represented as means of n = 3 independent biological replicates ± standard deviation, and statistical analysis was a one-way ANOVA followed by Dunnett’s multiple comparison test (F (22, 46) = 47.47). Asterisks indicate the following: (****): p < 0.0001.

Full size image

Next, we tested whether F. johnsoniae LolA1 and LolB1 could complement the deletion of lolA and lolB in E. coli. Since lolA and lolB are essential genes in E. coli, we first expressed the F. johnsoniae proteins LolA1 and LolB1 individually or together (LolA1–LolB1) in the E. coli MG1655 WT strain and then attempted to delete lolA or lolB. While deletion of lolA and lolB could be achieved when LolAEc and LolBEc were expressed in trans (Supplementary Fig. 5), we could not obtain any mutant when the F. johnsoniae proteins were expressed. Similar results were obtained when LolA2 and/or LolB2 proteins were expressed in E. coli. Lack of complementation by E. coli LolA and LolB of F. johnsoniae mutants and by F. johnsoniae LolA1 and LolB1 of E. coli mutants could not be ascribed to lack of expression of these proteins since all of them could be detected by mass spectrometry analysis (Supplementary Table 3). In conclusion, despite structural and physico-chemical similarities, E. coli and F. johnsoniae LolA and LolB proteins are not interchangeable.

LolA and LolB are conserved among Bacteroidota

We next explored if the F. johnsoniae LolA and LolB proteins were conserved in bacteria of the phylum Bacteroidota. To this aim, we performed an in silico sequence similarity search for homologs of the five F. johnsoniae LolA and LolB proteins in several Bacteroidota species. This analysis identified LolA and LolB homologs in all the analyzed species (Fig. 8 and Supplementary Table 4). In addition, while we found LolA1 and LolB1 homologs in all species, LolA2, LolB2, and LolA3 homologs seem to be more restricted. Among the species carrying only LolA1 and LolB1 homologs, there is C. canimorsus, which belongs to the family Flavobacteriaceae and is a normal oral commensal of dogs and cats which can cause severe infections in humans upon contact with these animals37. In C. canimorsus, LolA and LolB homologs, Ccan_16490 (LolA) and Ccan_17050 (LolB), are essential since attempts to delete their encoding genes failed. Regarding lolA2 and lolB2, both genes were always found to be encoded in loci dedicated to the synthesis and transport of a flexirubin-like pigments19, suggesting that LolA2 and LolB2 are specific to these processes.

Fig. 8: Conservation of LolA and LolB in Bacteroidota.
figure 8

Homologs of F. johnsoniae LolA and LolB proteins in several Bacteroidota species identified by DELTA Blast62. Phylogenetic tree based on NCBI taxonomy generated via phyloT67.

Full size image

To see whether the F. johnsoniae LolA1 and LolB1 and C. canimorsus LolA and LolB homologs share the same function in these bacteria, we first tested whether expression of C. canimorsus LolA (Ccan_16490) and LolB (Ccan_17050) could complement the deletion of lolA1 and lolB1 in F. johnsoniae respectively. Complementation with C. canimorsus LolA or LolB fully restored the ability to glide and secrete via the T9SS of the F. johnsoniae lolA1 and lolB1 mutants (Fig. 9a, b) as well as the growth and cell morphology phenotypes in MM (Fig. 9c, d).

Fig. 9: Heterologous complementation of LolA and LolB mutants of F. johnsoniae and C. canimorsus with LolA1 and LolB1 homologs.
figure 9

Gliding motility on MM agar plates after 48 h, starch degradation by T9-secreted amylases on LB starch plates after 24 h (a), and amylase activity of cell culture supernatants (b) of lolA1 and lolB1 F. johnsoniae mutants complemented with C. canimorsus lolA (lolACc) and lolB (lolBCc). Data in b are represented as means of n = 3 independent biological replicates ± standard deviation, and statistical analysis was a one-way ANOVA followed by Dunnett’s multiple comparison test (F (22, 46) = 47.47) (ns indicates p > 0.05). Growth in MM liquid medium (c) and phase-contrast microscopy images of bacteria grown in liquid MM medium for 16 h (d) of lolA1 and lolB1 F. johnsoniae mutants complemented with C. canimorsus lolA (lolACc) and lolB (lolBCc) (bar = 5 µm). Data in c are represented as means of n = 3 independent biological replicates ± standard deviation. Growth of serial dilution spots of C. canimorsus lolA and lolB mutants expressing F. johnsoniae lolA1 or lolB1 in trans on SB plates (e).

Full size image

We next tested whether the expression of F. johnsoniae LolA1 and LolB1 could bypass the lethality of the deletion of lolA and lolB of C. canimorsus. To test complementation with LolA1, we performed a plasmid exchange in the C. canimorsus lolA (Ccan_16490) mutant strain expressing plasmid-borne C. canimorsus lolA with the vector encoding lolA1 (see “Methods” for additional details). To test LolB1 complementation, we first expressed LolB1 in trans in the C. canimorsus WT strain and then deleted lolB (Ccan_17050). Both C. canimorsus lolA and lolB deletion mutants were viable when LolA1 or LolB1 were expressed, thus confirming that the F. johnsoniae and C. canimorsus proteins share similar functions (Fig. 9e). However, while complementation of lolB deletion in C. canimorsus with lolB1 did not result in any growth defect on rich medium, expression of lolA1 only partially complemented lolA deletion (Fig. 9e). Overall, these results suggest that homologs of F. johnsoniae LolA1 and LolB1 share the same function in C. canimorsus and that the same could be true in Bacteroidota in general.

Simultaneous deletion of all F. johnsoniae LolA and LolB homologs is not lethal and does not affect surface lipoprotein localization

Next, to see whether F. johnsoniae could tolerate the lack of all its LolA and LolB homologs, we generated a lolA1 lolA2 lolA3 lolB1 lolB2 quintuple mutant by sequentially deleting all genes. This indicates that the bacterium can perform its vital functions even in the absence of any LolA and LolB.

Finally, we tested whether surface-exposed lipoproteins are correctly localized in the absence of all LolA and LolB homologs in F. johnsoniae. To this end, we monitored surface lipoprotein exposure using a reporter lipoprotein: the sialidase (SiaC) from C. canimorsus. SiaC is an OM lipoprotein facing the periplasm where it is responsible for the cleavage of sialic acid from eukaryotic glycoproteins38. The addition of the lipoprotein export signal (LES) to SiaC (LES-SiaC) was shown by our group to be sufficient to localize it at the surface of C. canimorsus16,17.

We thus expressed SiaC and LES-SiaC in the F. johnsoniae WT and in the lolA1 lolA2 lolA3 lolB1 lolB2 quintuple mutant strain and verified their localization by immunofluorescence microscopy using anti-SiaC antibodies and secondary fluorescently labeled antibodies (Fig. 10). As expected, SiaC WT was not exposed at the bacterial surface of both strains while we found LES-SiaC surface exposed in both WT and LolAB lacking strains (Fig. 10), thus suggesting that surface-exposed lipoproteins correctly localize at the cell surface in the absence of any LolA and LolB proteins and thus that the pathway responsible for surface-lipoproteins localization is independent of LolA and LolB homologs of F. johnsoniae.

Fig. 10: Deletion of all LolA and LolB homologs of F. johnsoniae does not affect surface lipoproteins localization.
figure 10

Immunofluorescence microscopy images of F. johnsoniae WT and lolA1 lolA2 lolA3 lolB1 lolB2 mutant bacteria expressing sialidase (SiaC) or LES-sialidase (LES-SiaC) labeled with anti-SiaC serum (scale bar = 5 µm).

Full size image

Discussion

Here, we disclose the presence of LolB homologs in Bacteroidota, indicating that, in contrast to what was thought, the Lol pathway is conserved. In addition, we found that several LolA and LolB can co-exist in some Bacteroidota species such as F. johnsoniae, that encodes three LolA and two LolB homologs. We show that deletion of lolA1 and/or lolB1 results in the loss of gliding motility and T9 secretion. Proteomic data show that these two phenotypes can be explained by the significant reduction of key proteins and lipoproteins involved in gliding/T9 secretion in the OM of both lolA1 and lolB1 mutants. Indeed, the absence of OM lipoproteins GldJ and/or GldK is sufficient to completely abolish gliding and T9 secretion8,29. We believe that these lipoproteins might be mislocalized because they require LolA1 and then LolB1 to reach the OM. Two other proteins essential for gliding motility, SprB and SprD, were decreased in lolA1 and lolB1, though the significance did not meet our statistical parameters for both mutants (Fig. 3c and Supplementary Table 5). The OM of the lolA1 mutant was enriched in GldH (FC = 2.31), a lipoprotein necessary for the stability of GldJ and/or GldK8,24. This might be an attempt by F. johnsoniae to restore gliding motility and T9 secretion by stabilizing GldJ and GldK within the machinery.

In X. campestris and P. aeruginosa, it is known that lolA deletion and depletion, respectively, impact cell envelope stability, with increased sensitivity of the mutants to several OM stresses39,40. In E. coli, removal of lolA or lolB determines mislocalization of Lpp and RcsF that leads to cell death41. Here, we show that deletion of lolA1 and, to a lesser extent, lolB1 destabilizes the OM of F. johnsoniae. Hence, we observe substantial cell shape abnormalities for both mutants in the poor medium and even in the rich medium for the lolA1 single and lolA1lolB1 double mutants (Fig. 4b and Supplementary Fig. 3). We attempted to rationalize the weaker fitness of bacteria lacking LolA1 with our proteomic data. The severe membrane defects and cell material leakage observed for the lolA1 mutant (Supplementary Fig. 3) very likely resulted in the release of cytoplasmic proteins that we identified by proteomics (Supplementary Data 2). In total, the amount of four essential proteins of F. johnsoniae (Fjoh_0540, Fjoh_3469, Fjoh_5008, Fjoh_0105) was reduced in the OM of the lolA1 mutant while not in the lolB1 mutant (Supplementary Data 1). Besides, one of them is a lipoprotein homologous to E. coli BamD (Fjoh_3469, FC = 0.45), which is required for the activity of the BAM complex42. Malfunction of the BAM complex would be a sensible explanation for the great decrease in β-barrel proteins that we observed in the lolA1 OM. 13 SusC-like proteins (out of the 21 whose amount was reduced) were decreased along with their SusD-like partner upon deletion of lolA1. Such a diminution of β-barrel proteins is a modification of the OM proteome that might destabilize the OM, to the point of making it more sensitive to stresses (Fig. 5c). A possible explanation for the difference in fitness between lolA1 and lolB1 mutants could be that the IM essential complex LolCDE/F41 becomes stalled in absence of LolA1 to pick up lipoproteins, which would obstruct or at least hinder the lipoprotein transport pathway. On the other hand, deletion of lolB1 likely has no effect on the functioning of LolCDE/F, given their respective localization in the outer and inner membranes. The growth complementation and the partial restoration of cell shape aberrations in MM medium by MgSO4, a known stabilizer of LPS-LPS interactions, further support the idea that deletion of lolA1 or lolB1 disrupts OM stability.

In this work, we explored the structure of LolB1, based on our knowledge of E. coli LolB. The importance of the conserved protruding loop and the leucine 74 residue for LolB1 function (Fig. 6b) strongly suggests that E. coli LolB and F. johnsoniae LolB1 work in a similar fashion. In contrast, the lack of complementation of the F. johnsoniae lolA1 and lolB1 mutants by E. coli LolA and LolB could be due to a lack of interaction as a result of differences in the structures and/or physico-chemical properties between F. johnsoniae LolA1 and LolB1 and E. coli LolA and LolB (Fig. 1, Supplementary Table 1, Supplementary Figs. 1 and 2). Our data also show that proper activity of LolB1 necessitates a disordered C-terminal domain, which appears to be a unique feature of Bacteroidota LolB1 proteins and that is absent from E. coli LolB.

Lastly, we found that LolA2 and LolB2 are encoded in the locus of flexirubin synthesis and transport of F. johnsoniae, and that these two proteins are conserved in Bacteroidota that synthesize flexirubin or flexirubin-like pigments, which are thought to be localized in the OM (Fig. 8)19,21. Considering the ability of LolA and LolB-like proteins to bind hydrophobic moieties, this might suggest that LolA2 and LolB2 participate in the transport of either flexirubin/flexirubin precursors, or lipoproteins encoded in the locus. To our knowledge, this would be the first example of such a specialization of LolA and LolB-like proteins to a specific pathway and we aim to test this in the next future. Concerning LolA3, we could not observe any phenotype upon its deletion but its poor conservation and low prevalence in Bacteroidota might suggest a specific role of this protein restricted to some species. Whether this protein can interact with LolB1 and/or LolB2 and participate in different pathways requires further investigation. Surprisingly, we were able to generate a viable mutant strain devoid of any LolA or LolB protein. Essential OM lipoproteins like those part of the BAM and Lpt complexes are likely correctly localized in F. johnsoniae despite the absence of LolA and LoB homologs, strongly suggesting that an alternative LolA-LolB independent lipoprotein sorting pathway exists in Bacteroidota as already been suggested for E. coli41. In addition, we show that lipoproteins are still localized at the bacterial surface in the absence of LolA and LolB proteins thus suggesting that this specific class of lipoproteins does not require these elements of the Lol pathway for its localization. Overall, this study unveils the hidden diversity of LolA and LolB proteins which likely share a common function, i.e., the transport of lipidated cargos across the periplasm, but specialized over time to suit different pathways and organisms. Gene duplication events may have allowed some Bacteroidota species like F. johnsoniae to repurpose LolA and LolB proteins to the sole transport of lipoproteins involved in gliding motility and T9 secretion or to the synthesis/transport of outer membrane lipids such as flexirubin, for example. This diversification of lipoprotein transport routes fits with the extensive use of OM lipoproteins by Bacteroidota. We believe that these findings will contribute to a better understanding of lipoprotein trafficking in Gram-negative bacteria, a field of great importance that remains understudied outside of Proteobacteria.

Methods

Bacterial strains and growth conditions

Bacterial strains used in this work are listed in Supplementary Table 6. Unless otherwise stated, F. johnsoniae ATCC 17061 UW101 strains were routinely grown in Casitone Yeast Extract (CYE) medium (10 g/l casitone, 5 g/l yeast extract, 8 mM MgSO4 and 10 mM Tris-HCl pH 7.5) or Motility Medium (MM) (3.3 g/l casitone, 1.7 g/l yeast extract, 3.3 mM Tris-HCl pH 7.5) at 30°C. When required, the following concentrations of antibiotics were used: Gentamicin (Gm) at 20 μg/ml, Tetracycline (Tet) at 20 μg/ml, and Erythromycin (Em) at 100 μg/ml. E. coli strains were grown in lysogeny broth (LB) at 37 °C and the following concentrations of antibiotics were used accordingly: Ampicillin (Amp) at 100 μg/ml, Kanamycin (Kan) at 50 μg/ml, Chloramphenicol (Cm) at 30 μg/ml and Tetracycline (Tet) at 12.5 μg/ml. Capnocytophaga canimorsus 5 strains were routinely grown at 37°C in the presence of 5% CO2 on heart infusion agar (HIA) supplemented with 5% sheep blood (SB) plates with, when required, the following concentrations of antibiotics: Gentamicin (Gm) at 20 μg/ml, Cefoxitin (Cfx) at 10 μg/ml, Erythromycin (Em) at 10 μg/ml, and Tetracycline (Tet) at 10 μg/ml.

In silico search for LolA and LolB homologs

To search for LolA and LolB remote homologs, whole proteome structure predictions were realized for F. johnsoniae UW101 strain using the HHSearch suite43 with default parameters. The structures of E. coli LolA and LolB were predicted using the same program and parameters. An in-house Perl script was used to compare the hit list for each of the F. johnsoniae proteins with the hit list for E. coli LolA and LolB, with a cut-off value of 10−3. Proteins with identical templates were selected as potential candidates.

In silico modeling and characterization of LolA and LolB homologs

From the sequences of identified full-length F. johnsoniae LolA1 (Fjoh_2111), LolA2 (Fjoh_1085), LolB1 (Fjoh_1066), and LolB2 (Fjoh_1084), proteins were modeled using the Iterative Threading ASSEmbly Refinement (I-TASSER) protein structure predictor without specifying secondary structure preferences and additional distance restraints or templates44; models displaying the highest probability score were selected. Given the poor quality of the LolA3 (Fjoh_0605) I-TASSER model, the best ranking AlphaFold 3 model was chosen instead for representing the LolA3 structure45. The presence of signal peptides was determined using the SignalP 6.0 server46. As such, the N-terminal cleaved peptides were not considered. Electrostatic potentials and hydrophobicity scores were 3D mapped on the refined crystallographic structures of E. coli LolA (PDB entry: 1UA8) and LolB (PDB entry: 1IWL), as well as on the selected I-TASSER and AlphaFold 3 models of LolA and LolB variants from F. johnsoniae. For each protein, the corresponding PDB file was prepared for pKa and continuum solvation calculations with PROPKA 3.2 and PDB2PQR software in the AMBER force field, respectively. Equations of continuum electrostatics were solved using the Adaptive Poisson-Boltzmann Solver (APBS) software suite in the following conditions: pH 7.0, 298.15 K, 150 mM NaCl, 1.1 and 1.7 Å ionic radii for Na+ and Cl−, respectively. All calculation steps were carried out via the APBS/PDB2PQR website47. The resulting Poisson–Boltzmann electrostatic potentials were mapped on the van der Waals surface of LolA and LolB proteins, using a potential scale ranging from −3 kBT/e to +3 kBT/e. Regarding hydrophobicity computation, residues were colored according to Eisenberg’s normalized consensus hydrophobicity scale using the Color h script in the PyMOL software48. Scores were mapped on the van der Waals surface of LolA and LolB proteins. All the structures were visualized using the PyMOL Molecular Graphics System, Version 1.2r3pre, Schrödinger, LLC.

Construction of F. johnsoniae deletion strains

Suicide plasmids (Supplementary Table 7) for deletions in F. johnsoniae were constructed by amplifying the 2 kb chromosomal regions upstream and downstream of the target gene with specific primers (Supplementary Table 8) and cloned sequentially (or by Gibson assembly49 (NEB)) into the pYT354 suicide plasmid. Suicide plasmids were introduced into the appropriate F. johnsoniae background strain by triparental mating using E. coli Top10 as a donor and E. coli MT607 as a helper strain. Erythromycin resistance was used to select cells with chromosomally integrated plasmid. One of the resulting clones was grown overnight in CYE without antibiotics to allow for loss of the plasmid backbone and then plated on CYE agar containing 5% sucrose. Sucrose-resistant colonies were screened by PCR for the presence of the desired chromosomal modification.

Construction of plasmids for complementation in F. johnsoniae and C. canimorsus

Genes of interest were amplified from genomic DNA using specific primers (Supplementary Table 8) with Q5 DNA Polymerase. The expression plasmids pCP23-PermF or pMM47.A and the amplified genes were digested with appropriate restriction enzymes (New England Biolabs) and ligated with T4 ligase (New England Biolabs) O/N at 16 °C. The ligation products were transformed by heat shock or electroporation into E. coli Top10 and plated on LB Amp plates. Resistant clones were screened by PCR for the presence of the correct plasmid and constructs were checked by sequencing. Plasmids (Supplementary Table 7) were transferred to F. johnsoniae by triparental mating, and tetracycline resistance was used to select cells that received the plasmid. Plasmids were transferred to C. canimorsus by electroporation, and cefoxitin resistance was used to select cells that received the plasmid.

Motility assays on agar plates

To assess the motility of F. johnsoniae, strains were grown O/N in CYE liquid medium at 30 °C. In total, 5 × 107 bacteria were collected by centrifugation for 3 min at 5000×g. The resulting pellets were resuspended in 1 ml of PBS. Three microlitres of the resuspended cells were spotted on MM plates and incubated for 48 h at 30 °C. Pictures were taken with a Nikon CoolPix L29 camera.

Microscopic observations of cell movement on agar pads

Wild-type and mutant F. johnsoniae were examined for movement on agar pads by phase-contrast microscopy as described in ref. 50. Briefly, bacteria were grown overnight in MM at 25 °C without shaking, deposited on a 0.7% agar MM pad, and covered with a glass coverslip. After 5 min incubation at 25 °C, bacteria were filmed using an Axio Observer (Zeiss) microscope equipped with an Orca-Flash 4.0 camera (Hamamatsu) and the Zen Pro 3.9 software (Zeiss). Movies were mounted using the Microsoft Clipchamp version 3.1.

Amylase activity assays

F. johnsoniae strains were grown O/N in CYE liquid medium at 30 °C. For plate amylase activity assays, 5 × 107 bacteria were collected by centrifugation at 5000×g for 3 min. The resulting pellets were resuspended in 1 ml of PBS. Three microlitres of the resuspended cells were spotted on LB (0.2% starch (Merck)) and were incubated for 24 h at 30 °C. A solution of 1% KI and 1% iodine was poured on the agar for starch staining, and pictures were taken with a Nikon CoolPix L29 camera. For quantitative amylase activity assays, bacterial cultures were diluted to an OD600 of 0.05 in CYE and grown in a microplate reader in the same conditions as for the growth assays. All the strains were grown for 12 h, and after checking that they had all reached the same OD600, cultures were retrieved and centrifuged for 3 min at 5000×g. The supernatant was collected and filtered with 0.2 µm membranes to remove bacteria. Filtered supernatant was mixed with a 1% starch solution (0.2% final) and incubated for 4 h at 30°C, 160 rpm. Finally, 143 µl of the solution was mixed with 107 µl of 3,5-dinitrosalicylic acid (DNSA) 96 mM, boiled at 99 °C for 20 min, and absorbance was read at 540 nm with a SpectraMax iD3 microplate reader (Molecular Devices).

Membrane purification

Membranes were purified as described in ref. 26 with some modifications. F. johnsoniae liquid cultures (50 ml) of the WT, lolA1 mutant, and lolB1 mutant strains were grown O/N in CYE at 30°C, 160 rpm. In total, 2 × 1010 bacteria were collected by centrifugation (10 min at 7000×g, 4 °C), resuspended in 4 ml of buffer (HEPES 10 mM pH 7.4, 1 mM EDTA, EDTA-free protease inhibitor cocktail from a tablet (Roche)) and lysed by 3 passages through a cell disrupter at 2.4 kbar. The lysates were then centrifuged 10 min at 2500×g, 4 °C, to pellet unbroken cells and debris. The inner and outer membranes were precipitated through a first ultracentrifugation step (107 min at 55,000 rpm with a Beckman TLA-100.3 fixed-angle rotor, 4 °C). To solubilize the inner membrane, the pellets were resuspended in a solution of HEPES 10 mM pH 7.4 and N-lauroylsarcosine sodium salt 2% (sarcosyl) (Sigma-Aldrich) and were incubated on a roller shaker for 60 min at RT. To separate the membranes, a second ultracentrifugation step (identical settings as the first) was performed, and the outer membrane pellet was resuspended in 250 µl of HEPES 10 mM pH 7.4.

Verification of the purity of the membrane fractions

To verify for inner membrane contamination in the outer membrane fraction, an SDH activity assay was carried out51. During the OM purification, 200 µl were sampled right after cell lysis (total lysate fraction), 200 µl of supernatant right after the first ultracentrifugation step (periplasm + cytoplasm fraction), and 200 µl after full resuspension of the inner and outer membranes in HEPES (inner and outer membrane fraction). Inner membrane and outer membrane fractions were stored at the end of the purification. After membrane extraction, the protein concentration of the different fractions was quantified with a Bradford protein assay (Bio-rad). The fractions were diluted to 0.24 µg/µl of protein. A 96-well plate was filled with either 100 μl of sample or water. Then, 60 μl of the following reaction mix (final concentrations) was added to each well: 50 mM Tris-HCl (pH 8.0), 4 mM KCN, and 40 mM disodium succinate. After 5 min of incubation at RT, 20 μl of 4 mM DCIP and 20 µl of 2 mM PMS were subsequently added. Absorbance at 600 nm was measured using a SpectraMax iD3 microplate reader (Molecular Devices) every 36 s for 1 h at 25 °C. As an additional verification of outer membrane purity, 2 μg of protein was loaded on a 12% SDS-PAGE gel and visualized by silver staining. OM fractions from five independent biological replicates with low SDH activity and characteristic silver staining OM band patterns were analyzed by mass spectrometry.

Protein digestion prior to MS

The samples were treated using Filter-Aided Sample Preparation (FASP) using the following protocol:

To first wash the filter, 100 µl of formic acid 1% was placed in each Millipore Microcon 30 MRCFOR030 Ultracel PL-30 before centrifugation at 19,980×g (Ohaus 5515 R centrifuge) for 15 min. For each sample, 15 µg of proteins adjusted in 150 µl of urea buffer 8 M (urea 8 M in buffer Tris 0.1 M at pH 8.5) were placed individually in a column and centrifuged at 19,980×g for 15 min. The filtrate was discarded, and the columns were washed three times by adding 200 µl of urea buffer, followed by a centrifugation at 19,980×g for 15 min. For the reduction step, 100 µl of dithiothreitol (DTT) was added and mixed for 1 min at 400 rpm with a thermomixer before an incubation of 15 min at 24 °C. Samples were then centrifuged at 19,980×g for 15 min, the filtrate was discarded, and the filter was washed by adding 100 µl of urea buffer before another centrifugation at 19,980×g for 15 min. An alkylation step was performed by adding 100 µl of iodoacetamide ((IAA), in urea buffer) in the column and mixing at 400 rpm for 1 min in the dark before an incubation of 20 min in the dark and a centrifugation at 19,980×g for 15 min. To remove the excess of IAA, 100 µl of urea buffer was added and the samples were centrifuged at 19,980×g for 15 min. To quench the rest of IAA, 100 µl of DTT was placed on the column, mixed for 1 min at 400 rpm, and incubated for 15 min at 24 °C before centrifugation at 19,980×g for 15 min. To remove the excess DTT, 100 µl of urea buffer was placed on the column and centrifuged at 19,980×g for 15 min. The filtrate was discarded, and the column was washed three times by adding 100 µl of sodium bicarbonate buffer 50 mM (ABC), in ultrapure water) followed by centrifugation at 19,980×g for 15 min. The last 100 µl were kept at the bottom of the column to avoid evaporation. The digestion process was performed by adding 80 µl of mass spectrometry-grade trypsin (1/50 in ABC buffer) in the column and mixed at 300 rpm overnight at 24 °C, in the dark. The Microcon columns were placed on LoBind tubes of 1.5 ml and centrifuged at 19,980×g for 15 min. In total, 40 µl of ABC buffer was placed on the column before centrifugation at 19,980×g for 15 min. Two microlitres of trifluoroacetic acid (TFA) 10% in ultrapure water were added to the filtrate (0.2% TFA final). The samples were dried in a SpeedVac, resuspended in injection solvent (acetonitrile (ACN) 2%, formic acid 0.1%) for a final concentration of 250 ng/µl, and transferred to an injection vial.

Mass spectrometry

The digest was analyzed using nano-LC-ESI-MS/MS tims TOF Pro (Bruker, Billerica, MA, USA) coupled with a UHPLC nanoElute2 (Bruker). The different samples were analyzed with a gradient of 60 min. Peptides were separated by nanoUHPLC (nanoElute2, Bruker) on a 75 μm ID, 25 cm C18 column with integrated CaptiveSpray insert (Aurora, ionopticks, Melbourne) at a flow rate of 200 nl/min, at 50 °C. LC mobile phases A was water with 0.1% formic acid (v/v) and B ACN with formic acid 0.1% (v/v). Samples were loaded directly on the analytical column at a constant pressure of 800 bar. The digest (1 µl) was injected, and the organic content of the mobile phase was increased linearly from 2% B to 15% in 22 min, from 15% B to 35% in 38 min, from 35% B to 85% in 3 min. Data acquisition on the tims TOF Pro was performed using Hystar 6.1 and timsControl 2.0. tims TOF Pro data were acquired using 160 ms TIMS accumulation time, mobility (1/K0) range from 0.75 to 1.42 Vs/cm². Mass-spectrometric analysis was carried out using the parallel accumulation serial fragmentation (PASEF)52 acquisition method. One MS spectra followed by six PASEF MSMS spectra per total cycle of 1.16 s.

PEAKS proteomic analysis

Data analysis was performed using PEAKS Studio 11 with an ion mobility module and Q module for label-free quantification (Bioinformatics Solutions Inc., Waterloo, ON). Protein identifications were conducted using the PEAKS search engine with 20 ppm as parent mass error tolerance and 0.05 Da as fragment mass error tolerance. Carbamidomethylation was allowed as fixed modification, oxidation of methionine and acetylation (N-term) as variable modification. Enzyme specificity was set to trypsin, and the maximum number of missed cleavages per peptide was set to two. The peak lists were searched against the F. johnsoniae UW101 proteome from Uniprot (220718-5,021 entries) and a contaminants database. Peptide spectrum matches and protein identifications were normalized to less than 1.0% false discovery rate.

The label-free quantitation (LFQ) method is based on the expectation–maximization algorithm on the extracted ion chromatograms of the three most abundant unique peptides of a protein to calculate the area under the curve53. For the quantitation, mass error and ion mobility tolerance were set respectively to 20 ppm and 0.08 1/k0. For the label-free quantitation results, the peptide quality score was set to be ≥20, and the protein significance score threshold was set to 20. The significance score is calculated as the −10 log10 of the significance testing p-value (0.01). ANOVA was used as the significance testing method. Modified peptides were excluded and only proteins with at least two peptides were used for the quantitation. Total ion current was used to calculate the normalization factors.

In silico characterization of the proteins identified by label-free mass spectrometry

The presence of signal peptide I or II was predicted using the SignalP 6.0 server46. Proteins devoid of any signal peptide were excluded from further analyses. Proteins with SPII (lipoproteins) were manually checked for the presence of the LES (surface lipoproteins)16,17. Localization of the proteins was manually checked, according to the signal peptide, the predicted 3D structure, Interpro domains, and prediction by PSORTb 3.0.354. Proteins belonging to SUS-like systems were annotated with the CAZy database55. The essentiality of the proteins was determined thanks to a transposon sequencing (Tn_seq) analysis previously realized in our group. Proteins were functionally annotated using the MicroScope platform56, which employs data from EggNOG 5.057 and EggNOG-mapper 2.158.

Growth and OM stress tolerance assays

F. johnsoniae strains were grown O/N in CYE liquid medium at 30°C, 160 rpm. Cultures were diluted to an OD600 of 0.05 and washed once with PBS. For growth assays, cells were resuspended in fresh CYE or MM. For stress tolerance assays, cells were resuspended in fresh CYE in the absence or presence of the following compounds: Polymyxin B (2, 20 and 40 μg/ml), EDTA (0.2 and 1 mM) and SDS (0.001 and 0.005%). Optical density at 600 nm was measured every 10 minutes during 24 h at 30°C with continuous linear shaking (567 cpm) using an EPOCH2 Microplate Reader (BioTek).

Phase-contrast microscopy

For live imaging, cells were grown O/N in regular CYE. Cultures were then diluted to an OD600 of 0.05 in 10 ml of CYE low magnesium (4 mM MgSO4) or MM, in flasks. Cells were incubated for 16 h at 30 °C, 160 rpm, and directly spotted on a microscope glass slide. Pictures were acquired with an Axio Observer (Zeiss) microscope equipped with an Orca-Flash 4.0 camera (Hamamatsu) and the Zen Pro 3.9 software (Zeiss).

Transmission electron microscopy

Bacterial samples for electron microscopy were prepared as described in ref. 59 with some modifications. F. johnsoniae was grown O/N in regular CYE. Cultures were then diluted to an OD600 of 0.05 in 10 ml of CYE low magnesium (4 mM MgSO4) in flasks and incubated for 16 h at 30 °C, 160 rpm. The fixation procedure was performed as follows: 2 ml of bacterial culture was centrifuged for 3 min at 5000×g, and the pellet was resuspended in 400 µl of a solution of glutaraldehyde 2.5% and cacodylate 0.1% (pH 7.4). After 2.5 h of incubation at 4 °C, bacteria were washed three times with cacodylate 0.2%, resuspended in a solution of osmic acid 2% and cacodylate 0.1%, and incubated for one additional hour at 4 °C. Then, the bacteria were washed two more times with cacodylate 0.2%. Samples were dehydrated by incubation with increasing concentrations of ethanol (30%, 50%, 70%, 85%, and 100%) at RT. For the embedding in resin, samples were first washed four times with propylene oxide and then incubated in three propylene oxide/resin solutions: 15 min in 75% propylene oxide/25% resin, 20 min in 50% propylene oxide/50% resin, and 20 min in 25% propylene oxide/75% resin. Finally, pellets were embedded in pure epoxy resin. The resin was dried by incubation at 37 °C O/N, 24 h of incubation at 45 °C, and 3 days at 60 °C. Ultrathin sections were cut with a DiATOME ultra 45° diamond knife and visualized with a FEI Tecnai T10 electron microscope at 60–80 kV. Images were acquired by the software Item of Olympus with an Olympus Megaview 1024 × 1024 pixels camera.

Complementation of lolB1 mutant with mutated variants of LolB1

lolB1 (Fjoh_1066) was amplified with oligonucleotides containing the desired mutation (L74E, Δ73–76, C17G) (Supplementary Table 8). For the deletion of the C-terminal domain (223–243), Phe223 was substituted with a stop codon. The mutated genes were then cloned into pCP23-PermF, and the resulting plasmids were transferred to the F. johnsoniae lolB1 mutant by triparental mating. To add a 6xHis tag at the C-terminus of the WT and mutated LolB1 variants, the genes were amplified with a forward oligonucleotide and a reverse one devoid of the stop codon (Supplementary Table 8) and cloned into pCP23-PermF in frame with the 6XHis tag encoded in the plasmid.

Detection of His-tagged LolB variants by Western-Blot

For Western Blot analyses, bacteria were grown in CYE liquid medium supplemented with tetracycline till the stationary phase, and 5 × 108 bacteria were collected by centrifugation at 5000×g for 3 min. The pellet was resuspended in 80 µl of sterile water and 20 µl of SDS-PAGE buffer 5×. After heating the samples for 5 min at 98 °C, 10 μl were loaded on a 12% SDS-PAGE gel. After migration, the proteins were transferred onto a nitrocellulose membrane with a Trans-Blot Turbo Transfer System (Bio-Rad). Proteins were detected with rabbit anti-His (1/5000) (PM032, MBL) or rabbit anti-GroEL (1/1600) (G6535, Sigma-Aldrich) primary antibodies and polyclonal swine-HRP anti-rabbit (1/5000) (P0217, Dako) secondary antibodies. Membranes were developed using a KPL LumiGLO Reserve Chemiluminescent Substrate Kit (SeraCare), and images were captured using a GE Healthcare Amersham Imager 600.

Deletion of lolA and lolB and heterologous complementation in E. coli

For the deletion of lolA and lolB in E. coli MG1655, forward and reverse primers were designed respectively with the start and end of the gene of interest sequence flanked with regions that anneal on the pKD4 plasmid containing the KanR gene to be amplified: oligonucleotides 8675/8679 and 8677/8680 for lolA and lolB deletion respectively (Supplementary Table 8)60. The E. coli MG1655 mini-λ-Tet strain was transformed with the pBAD33-Ara inducible plasmid expressing the following genes: lolA, lolB, lolA1, lolB1, lolA1 and lolB1, lolA2, lolB2, lolA2, and lolB2. The plasmid-borne complemented strains were grown O/N at 30 °C in LB Tet Cm and 1 ml of the O/N liquid culture was transferred to 100 ml of LB Tet Cm.

The λ red system was then induced by placing the cultures in a 42 °C water bath for 15 min at 220 rpm. Cells were then made electro-competent and transformed with PCR fragments for the deletion of either lolA or lolB chromosomal loci by electroporation, then resuspended in 1 ml of LB 0.2% arabinose (Ara) and incubated for 1 h at 37 °C. Hundred microlitres of the cells were then plated on LB Kan Cm 0.2% Ara plates. When present, colonies grown after 24 h and/or 48 h were checked for deletion of either lolA or lolB by PCR.

Verification of the in-trans expression of LolA and LolB homologs by mass spectrometry

The following strains were grown O/N in liquid CYE Tet for F. johnsoniae and LB Cm for E. coli: F. johnsoniae ΔlolA1 ΔlolB1 + pCP23-PermFlolAlolB (E. coli), E. coli MG1655 WT + pBAD33− lolA1lolB1 and E. coli MG1655 WT+ pBAD33-lolA2lolB2. Eighty microlitres of cultures at OD600 = 1 were collected and resuspended with 20 μL SDS Buffer 5×. Protein concentrations of the total lysates were determined by Pierce 660 assay (Thermo Scientific, Waltham, MA, USA) and were analyzed by Mass spectrometry. Digestion of the samples, liquid chromatography, and mass spectrometry were realized as described.

Data processing using scaffold for protein identification

The MS/MS samples were analyzed using Mascot (Matrix Science, London, UK; version 2.7.0). For heterologous complementation samples analysis, Mascot was set up to search the FLAJ1_200130 database (5023 entries) to which the E. coli LolA (P61316) and LolB (P61320) protein sequences were added or E. coli K12-McpR_200814 database (11002 entries) to which the F. johnsoniae LolA1 (A5FI22) and LolB1 (A5FL25) protein sequences were added assuming the digestion enzyme trypsin. For LolB1 variants samples analysis, Mascot was set up to search the FLAJ1_200130 database (5023 entries) to which the protein sequences of F. johnsoniae LolB1L74E, LolB1∆73-76 and LolB1∆223-243 all with a C-terminal 6XHis tag were added assuming the digestion enzyme trypsin. Mascot was searched with a fragment ion mass tolerance of 0050 Da and a parent ion tolerance of 15 PPM. Carbamidomethyl of cysteine and j + 59 of leucine/isoleucine indecision were specified in Mascot as fixed modifications. Deamidation of asparagine and glutamine, oxidation of methionine and acetyl of the n-terminus were specified in Mascot as variable modifications. Scaffold (version Scaffold_4.11.0, Proteome Software Inc., Portland, OR) was used to validate MS/MS-based peptide and protein identifications. Peptide identifications were accepted if they could be established at greater than 91.0% probability to achieve an FDR less than 1.0% by the Scaffold Local FDR algorithm. Protein identifications were accepted if they could be established at greater than 72.0% probability to achieve an FDR less than 1.0% and contained at least 2 identified peptides. Protein probabilities were assigned by the Protein Prophet algorithm61. Proteins that contained similar peptides and could not be differentiated based on MS/MS analysis alone were grouped to satisfy the principles of parsimony. Proteins sharing significant peptide evidence were grouped into clusters. Proteins of interest were checked for identification.

Conservation of LolA and LolB in bacteroidota

A Delta-blast62 sequence similarity search was conducted on the 30 Bacteroidota species: Bacteroides fragilis NCTC 9343, Bacteroides ovatus ATCC 8483, Bacteroides thetaioathaomicron DSM 2079, Bergeyella zoohelcum ATCC 43767, Capnocytophaga canimorsus Cc5, Capnocytophaga canis CcD38, Capnocytophaga cynodegmi DSM 19736, Capnocytophaga gingivalis ATCC 33624, Capnocytophaga ochracea DSM 7271, Chitinophaga filiformis DSM 527, Chitinophaga pinensis DSM 2588, Croceibacter atlanticus HTCC2559, Cytophaga hutchinsonii ATCC 33406, Flavobacterium columnare NBRC 100251, Flavobacterium johnsoniae ATCC 17061, Elizabethkingia meningoseptica NBRC 12535, Flavobacterium psychrophilum DSM 3660, Flavobacterium succinicans LMG 10402, Flexibacter flexilis NBRC 15060, Gramella forsetii KT0803, Kordia algicida OT-1, Polaribacter irgensii 23-P, Porphyromonas gingivalis ATCC 33277, Prevotella intermedia ATCC 25611, Prevotella melaninogenica ATCC 25845, Riemerella anatipestifer ATCC 11845, Sphingobacterium mizutaii NBRC 14946, Sporocytophaga myxococcoides DSM 11118, Xanthomarina gelatinilytica AK20, Zobellia galactanivorans DsiJT, using the five LolA and LolB protein sequences of F. johnsoniae ATCC 17061 UW101 as queries: LolA1 (WP_081432686.1), LolA2 (WP_012023170.1), LolA3 (WP_012022695.1), LolB1 (WP_012023151.1) and LolB2 (WP_012023169.1). The genomic neighborhood of all hits with a Delta-blast E value ≤ 0.001 was inspected using MaGe63. The structure of the corresponding proteins was predicted using AlphaFold server (with default parameters)45 and compared with the corresponding structures of the F. johnsoniae initial queries by manual inspection. This resulted in a list of 93 putative homologs. The phylogenetic tree based on NCBI taxonomy was generated via phyloT64,65. Conservation of the C-terminal domain of LolB1 homologs was performed by manual inspection on AlphaFold models.

Deletion of lolA and lolB and heterologous complementation in C. canimorsus

To obtain the C. canimorsus lolA (Ccan_16490) mutant strain expressing F. johnsoniae lolA1, we transformed the pMM47-lolA1 (CfxR) plasmid into C. canimorsus lolA harboring pFL63 plasmid (TetR) which expresses WT C. canimorsus lolA). We selected cefoxitin-resistant colonies and subcultured them 3 times on cefoxitin-containing SB plates. Colonies were checked for tetracycline sensitivity, and loss of the pFL63 plasmid was confirmed by PCR. To obtain the C. canimorsus lolB (Ccan_17050) mutant strain expressing F. johnsoniae lolB1 we first transformed plasmid pMM47-lolB1 into WT C. canimorsus and then deleted gene Ccan_17050. Deletion of Ccan_17050 in the C. canimorsus lolB1-expressing strain was performed by amplification and cloning into pYT354 suicide plasmid of the 500 bases of the chromosomal regions upstream and downstream of Ccan_17050 (Supplementary Tables 7 and 8). The suicide plasmid was introduced into the C. canimorsus pMM47-lolB1 strain by triparental mating using E. coli Top10 as donor and E. coli MT607 as a helper strain. Erythromycin resistance was used to select cells with chromosomally integrated plasmid. One of the resulting clones was grown overnight on an SB plate without antibiotics to allow for loss of the plasmid backbone and then plated on an SB plate containing 3% sucrose. Sucrose-resistant colonies were screened by PCR for the presence of the Ccan_17050 deletion.

Immunofluorescence microscopy of sialidase

F. johnsoniae WT and lolA1 lolA2 lolA3 lolB1 lolB2 strains harboring plasmid pCP23-PermFsiaC or pCP23-PermF-LES-siaC were grown O/N in CYE Tet liquid medium at 30 °C. In total, 5 × 108 bacteria were collected by centrifugation at 5000×g for 3 min and resuspended in 1 ml of PBS. Cells were collected by centrifugation at 4000×g for 5 min and resuspended in 200 μl of a PBS–BSA 1% solution and incubated for 30 min at RT. Cells were centrifuged 5 min at 4000×g and resuspended in 200 μl of PBS 1/2000 diluted rabbit anti-SiaC serum and incubated for 30 min at RT. Cells were washed 3 times with PBS and resuspended in 200 μl of PBS 1/500 diluted donkey anti-rabbit AlexaFluor-488TM (Thermofisher) and incubated 30 min at RT in the dark. After another 3 washes with PBS, cells were fixed with 200 μl of PFA 4% for 15 min in the dark. Cells were washed once with PBS and stored at 4 °C prior to analysis. Labeled bacteria were spotted on 1% agarose PBS pads and pictures were taken using an Axio Observer (Zeiss) microscope equipped with an Orca-Flash 4.0 camera (Hamamatsu) and the Zen Pro 3.9 software (Zeiss).

Statistics and reproducibility

For quantitative amylase activity assays, growth curve charts and OM stress tolerance assays results are presented as means of n = 3 independent biological replicates with standard deviations. The statistical analyses performed are given in the figure legends. p < 0.05 was considered statistically significant, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.

Reporting summary

Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article.

Related Articles

Gut microbiota-derived hexa-acylated lipopolysaccharides enhance cancer immunotherapy responses

The gut microbiome modulates immunotherapy treatment responses, and this may explain why immune checkpoint inhibitors, such as anti-PD-1, are only effective in some patients. Previous studies correlated lipopolysaccharide (LPS)-producing gut microbes with poorer prognosis; however, LPS from diverse bacterial species can range from immunostimulatory to inhibitory. Here, by functionally analysing faecal metagenomes from 112 patients with melanoma, we found that a subset of LPS-producing bacteria encoding immunostimulatory hexa-acylated LPS was enriched in microbiomes of clinical responders. In an implanted tumour mouse model of anti-PD-1 treatment, microbiota-derived hexa-acylated LPS was required for effective anti-tumour immune responses, and LPS-binding antibiotics and a small-molecule TLR4 antagonist abolished anti-PD-1 efficacy. Conversely, oral administration of hexa-acylated LPS to mice significantly augmented anti-PD-1-mediated anti-tumour immunity. Penta-acylated LPS did not improve anti-PD-1 efficacy in vivo and inhibited hexa-acylated LPS-induced immune activation in vitro. Microbiome hexa-acylated LPS therefore represents an accessible predictor and potential enhancer of immunotherapy responses.

Iron homeostasis and ferroptosis in muscle diseases and disorders: mechanisms and therapeutic prospects

The muscular system plays a critical role in the human body by governing skeletal movement, cardiovascular function, and the activities of digestive organs. Additionally, muscle tissues serve an endocrine function by secreting myogenic cytokines, thereby regulating metabolism throughout the entire body. Maintaining muscle function requires iron homeostasis. Recent studies suggest that disruptions in iron metabolism and ferroptosis, a form of iron-dependent cell death, are essential contributors to the progression of a wide range of muscle diseases and disorders, including sarcopenia, cardiomyopathy, and amyotrophic lateral sclerosis. Thus, a comprehensive overview of the mechanisms regulating iron metabolism and ferroptosis in these conditions is crucial for identifying potential therapeutic targets and developing new strategies for disease treatment and/or prevention. This review aims to summarize recent advances in understanding the molecular mechanisms underlying ferroptosis in the context of muscle injury, as well as associated muscle diseases and disorders. Moreover, we discuss potential targets within the ferroptosis pathway and possible strategies for managing muscle disorders. Finally, we shed new light on current limitations and future prospects for therapeutic interventions targeting ferroptosis.

Type 2 immunity in allergic diseases

Significant advancements have been made in understanding the cellular and molecular mechanisms of type 2 immunity in allergic diseases such as asthma, allergic rhinitis, chronic rhinosinusitis, eosinophilic esophagitis (EoE), food and drug allergies, and atopic dermatitis (AD). Type 2 immunity has evolved to protect against parasitic diseases and toxins, plays a role in the expulsion of parasites and larvae from inner tissues to the lumen and outside the body, maintains microbe-rich skin and mucosal epithelial barriers and counterbalances the type 1 immune response and its destructive effects. During the development of a type 2 immune response, an innate immune response initiates starting from epithelial cells and innate lymphoid cells (ILCs), including dendritic cells and macrophages, and translates to adaptive T and B-cell immunity, particularly IgE antibody production. Eosinophils, mast cells and basophils have effects on effector functions. Cytokines from ILC2s and CD4+ helper type 2 (Th2) cells, CD8 + T cells, and NK-T cells, along with myeloid cells, including IL-4, IL-5, IL-9, and IL-13, initiate and sustain allergic inflammation via T cell cells, eosinophils, and ILC2s; promote IgE class switching; and open the epithelial barrier. Epithelial cell activation, alarmin release and barrier dysfunction are key in the development of not only allergic diseases but also many other systemic diseases. Recent biologics targeting the pathways and effector functions of IL4/IL13, IL-5, and IgE have shown promising results for almost all ages, although some patients with severe allergic diseases do not respond to these therapies, highlighting the unmet need for a more detailed and personalized approach.

Microbial phosphorus recycling in soil by intra- and extracellular mechanisms

Rising global stoichiometric imbalance between increasing nitrogen (N) availability and depleting phosphorus (P) resources increases the importance of soil microbial P recycling. The contribution of extra- versus intracellular P (re-)cycling depending on ecosystem nutrient status is vastly unclear, making soil microorganisms a blind spot in our understanding of ecosystem responses to increasing P deficiency. We quantified P incorporation into microbial DNA and phospholipids by 33P labeling under contrasting conditions: low/high P soil × low/high carbon (C)NP application. By combining 33P and 14C labeling with tracing of microbial community biomarkers and functional genes, we disengaged the role of DNA and phospholipids in soil P cycling. Microorganisms in low P soil preferentially allocated P to phospholipids with an acceleration of phospholipids metabolism driven by C addition, which was strongly related to high abundances of microbial community members (e.g. some G-) with a fast phospholipids turnover. In high P soil, however, more P was allocated to DNA with a microbial functional shift towards DNA synthesis to support a replicative growth when sufficient C was supplied, which was coupled with a strong enrichment of fungal copiotrophs and microbial genes coding DNA primase. Consequently, adaptation to low P availability accelerated microbial intracellular P recycling through reutilization of the P stored in phospholipids. However, microorganisms under high P availability commonly adopted extracellular P recycling with release and reuse of DNA P by microbial death-growth dynamics. These results advance our understanding on microbial adaptation to P deficiency in soil by regulating component-specific P pathways and reflect the specific functions of phospholipids and DNA for P recycling.

Targeting of TAMs: can we be more clever than cancer cells?

With increasing incidence and geography, cancer is one of the leading causes of death, reduced quality of life and disability worldwide. Principal progress in the development of new anticancer therapies, in improving the efficiency of immunotherapeutic tools, and in the personification of conventional therapies needs to consider cancer-specific and patient-specific programming of innate immunity. Intratumoral TAMs and their precursors, resident macrophages and monocytes, are principal regulators of tumor progression and therapy resistance. Our review summarizes the accumulated evidence for the subpopulations of TAMs and their increasing number of biomarkers, indicating their predictive value for the clinical parameters of carcinogenesis and therapy resistance, with a focus on solid cancers of non-infectious etiology. We present the state-of-the-art knowledge about the tumor-supporting functions of TAMs at all stages of tumor progression and highlight biomarkers, recently identified by single-cell and spatial analytical methods, that discriminate between tumor-promoting and tumor-inhibiting TAMs, where both subtypes express a combination of prototype M1 and M2 genes. Our review focuses on novel mechanisms involved in the crosstalk among epigenetic, signaling, transcriptional and metabolic pathways in TAMs. Particular attention has been given to the recently identified link between cancer cell metabolism and the epigenetic programming of TAMs by histone lactylation, which can be responsible for the unlimited protumoral programming of TAMs. Finally, we explain how TAMs interfere with currently used anticancer therapeutics and summarize the most advanced data from clinical trials, which we divide into four categories: inhibition of TAM survival and differentiation, inhibition of monocyte/TAM recruitment into tumors, functional reprogramming of TAMs, and genetic enhancement of macrophages.

Responses

Your email address will not be published. Required fields are marked *